EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The syndrome of inappropriate antidiuretic hormone associated with nasal and paranasal malignant tumors

Shoutao Dang, Shurong Zhang, Jingyang Zhao, Xinyu Li, Wei Li

European Archives of Oto-Rhino-Laryngology · 2024

DOI: 10.1007/s00405-023-08347-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2024. Verfasst von Shoutao Dang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China. Hauptthemen laut MEDLINE: Inappropriate ADH Syndrome, Hyponatremia, Esthesioneuroblastoma, Olfactory, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate the clinical characteristics of the syndrome of inappropriate antidiuretic hormone (SIADH) associated with nasal and paranasal malignant tumors.

Methods

Patients with locally advanced or recurrence/metastatic malignant tumors of the nasal and paranasal sinuses were included. The SIADH was diagnosed according to the diagnostic criteria. The clinical characteristics of SIADH patients were retrospectively analyzed.

Results

Six patients (6/188, 3.2%) met the diagnostic criteria of SIADH, including four olfactory neuroblastoma (4/26, 15.4%), one neuroendocrine carcinoma (1/9, 11.1%), and one squamous cell carcinoma (1/63, 1.6%). Five patients (83.3%) had severe hyponatremia; however, the hyponatremia could be improved by fluid restriction or tolvaptan. Three patients' SIADH were recovered during the chemotherapy and the other three were recovered after the surgery.

Conclusion

The incidence of SIADH associated with nasal and paranasal malignant tumors is relatively more common in olfactory neuroblastoma and neuroendocrine carcinoma. The hyponatremia caused by SIADH may be corrected by fluid restriction or tolvaptan, and the SIADH may be recovered through anti-tumor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inappropriate ADH SyndromeHyponatremiaEsthesioneuroblastoma, OlfactoryCarcinoma, NeuroendocrineNose NeoplasmsHumansTolvaptanRetrospective StudiesNasal Cavity

Stichwörter der Autor:innen

HyponatremiaNasal and paranasal tumorsOlfactory neuroblastomaSyndrome of inappropriate secretion of antidiuretic hormone

Substanzen

Tolvaptan

Autor:innen und Institutionen

  • Cancer Center, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
  • Cancer Center, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China. weili8989@ccmu.edu.cn.

Zitieren

APA

Dang, S., Zhang, S., Zhao, J., Li, X., & Li, W. (2024). The syndrome of inappropriate antidiuretic hormone associated with nasal and paranasal malignant tumors. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-023-08347-5

Vancouver

Dang S, Zhang S, Zhao J, Li X, Li W. The syndrome of inappropriate antidiuretic hormone associated with nasal and paranasal malignant tumors. European Archives of Oto-Rhino-Laryngology. 2024. doi:10.1007/s00405-023-08347-5

BibTeX
@article{Dang2024,
  author = {Dang, Shoutao and Zhang, Shurong and Zhao, Jingyang and Li, Xinyu and Li, Wei},
  title = {The syndrome of inappropriate antidiuretic hormone associated with nasal and paranasal malignant tumors},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2024},
  doi = {10.1007/s00405-023-08347-5}
}
Kostenlos starten →